David Ussery and Brian Delavan discuss bioinformatics into TB surveillance, presenting a new approach to tackling this ...

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a ...

The laboratory informatics market is projected to reach $8.7 billion by 2029, reflecting the accelerating pace of digital transformation. As organisations strive to standardise and optimise data ...

Exosomes, the small extracellular vesicles secreted by nearly all cell types, have emerged as powerful players in intercellular communication and potential biomarkers for disease diagnosis and therapy ...

New ILR School-led research offers a comprehensive overview of the role of health information technology (IT) in the ...

Breast cancer remains a global challenge, marked by diverse patient responses to treatments and varying prognoses. The ...

Experiments on battery electrodes and fuel cell catalysts while they're being used - operando spectroscopy - can revolutionise our understanding of these crucial materials. Clare Sansom reports ...

Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

QIAGEN today announced the official opening of a new data center in Melbourne, Australia, designed to strengthen its global bioinformatics leadership position in this region of the world. This latest ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.